Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Keks

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Psycho-Oncology|March 1, 1997
Cognitive-existential group therapy for patients with primary breast cancer--techniques and themesD W Kissane, S Bloch, P Miach, et al.
The American Journal of Psychiatry|April 1, 1996
Problem of diagnosis in postmortem brain studies of schizophreniaC Hill, N Keks, S Roberts, et al.
Molecular Psychiatry|March 1, 1996
The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophreniaB Dean, J M Crook, K Opeskin, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxetineL Naylor, B Dean, K Opeskin, et al.
Biological Psychiatry|November 15, 1995
Gonadotropin response to naloxone challenge in female and male psychotic patients: a pilot studyJ Kulkarni, A de Castella, D Smith, et al.
Journal of Neurochemistry|March 1, 1995
[3H]paroxetine binding is altered in the hippocampus but not the frontal cortex or caudate nucleus from subjects with schizophreniaB Dean, K Opeskin, G Pavey, et al.
The Australian and New Zealand Journal of Psychiatry|December 1, 1989
Origins and establishment of the schizophrenia research programme at Royal Park Psychiatric HospitalD L Copolov, P D McGorry, N Keks, et al.
Behavioural Brain Research|January 1, 1996
Serotonin2 receptors and the serotonin transporter in the schizophrenic brainB Dean, W Hayes, K Opeskin, et al.
Acta Psychiatrica Scandinavica|November 1, 1994
The Australian multicentre double-blind comparative study of remoxipride and thioridazine in schizophreniaN Keks, J McGrath, T Lambert, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Psycho-Oncology|March 1, 1997
Cognitive-existential group therapy for patients with primary breast cancer--techniques and themesD W Kissane, S Bloch, P Miach, et al.
The American Journal of Psychiatry|April 1, 1996
Problem of diagnosis in postmortem brain studies of schizophreniaC Hill, N Keks, S Roberts, et al.
Molecular Psychiatry|March 1, 1996
The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophreniaB Dean, J M Crook, K Opeskin, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxetineL Naylor, B Dean, K Opeskin, et al.
Biological Psychiatry|November 15, 1995
Gonadotropin response to naloxone challenge in female and male psychotic patients: a pilot studyJ Kulkarni, A de Castella, D Smith, et al.
Journal of Neurochemistry|March 1, 1995
[3H]paroxetine binding is altered in the hippocampus but not the frontal cortex or caudate nucleus from subjects with schizophreniaB Dean, K Opeskin, G Pavey, et al.
The Australian and New Zealand Journal of Psychiatry|December 1, 1989
Origins and establishment of the schizophrenia research programme at Royal Park Psychiatric HospitalD L Copolov, P D McGorry, N Keks, et al.
Behavioural Brain Research|January 1, 1996
Serotonin2 receptors and the serotonin transporter in the schizophrenic brainB Dean, W Hayes, K Opeskin, et al.
Acta Psychiatrica Scandinavica|November 1, 1994
The Australian multicentre double-blind comparative study of remoxipride and thioridazine in schizophreniaN Keks, J McGrath, T Lambert, et al.
Pageof 2